These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35149191)

  • 1. Bioconjugation strategies and clinical implications of Interferon-bioconjugates.
    Hauptstein N; Meinel L; Lühmann T
    Eur J Pharm Biopharm; 2022 Mar; 172():157-167. PubMed ID: 35149191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo.
    Ank N; West H; Bartholdy C; Eriksson K; Thomsen AR; Paludan SR
    J Virol; 2006 May; 80(9):4501-9. PubMed ID: 16611910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type I interferons in the pathogenesis and treatment of canine diseases.
    Klotz D; Baumgärtner W; Gerhauser I
    Vet Immunol Immunopathol; 2017 Sep; 191():80-93. PubMed ID: 28895871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of antiviral effect of type I, II, and III interferons on direct-acting antiviral-resistant hepatitis C virus.
    Hamana A; Takahashi Y; Uchida T; Nishikawa M; Imamura M; Chayama K; Takakura Y
    Antiviral Res; 2017 Oct; 146():130-138. PubMed ID: 28864074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Type III Interferons in Human Disease.
    Malik AE; Issekutz TB; Derfalvi B
    Clin Invest Med; 2021 Jun; 44(2):E5-18. PubMed ID: 34152702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferons lambda, new cytokines with antiviral activity.
    Lopušná K; Režuchová I; Betáková T; Skovranová L; Tomašková J; Lukáčiková L; Kabát P
    Acta Virol; 2013; 57(2):171-9. PubMed ID: 23600875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somnogenic effects of rabbit and recombinant human interferons in rabbits.
    Kimura M; Majde JA; Toth LA; Opp MR; Krueger JM
    Am J Physiol; 1994 Jul; 267(1 Pt 2):R53-61. PubMed ID: 7519411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basal interferon signaling and therapeutic use of interferons in controlling rotavirus infection in human intestinal cells and organoids.
    Hakim MS; Chen S; Ding S; Yin Y; Ikram A; Ma XX; Wang W; Peppelenbosch MP; Pan Q
    Sci Rep; 2018 May; 8(1):8341. PubMed ID: 29844362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interferon system of teleost fish.
    Robertsen B
    Fish Shellfish Immunol; 2006 Feb; 20(2):172-91. PubMed ID: 15939626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of type I and type III interferons by a secreted glycoprotein from Yaba-like disease virus.
    Huang J; Smirnov SV; Lewis-Antes A; Balan M; Li W; Tang S; Silke GV; Pütz MM; Smith GL; Kotenko SV
    Proc Natl Acad Sci U S A; 2007 Jun; 104(23):9822-7. PubMed ID: 17517620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiproliferative effects of interferons on human melanoma cells in the human tumor colony-forming assay.
    Schiller JH; Willson JK; Bittner G; Wolberg WH; Hawkins MJ; Borden EC
    J Interferon Res; 1986 Dec; 6(6):615-25. PubMed ID: 2437222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Murine interferon lambdas (type III interferons) exhibit potent antiviral activity in vivo in a poxvirus infection model.
    Bartlett NW; Buttigieg K; Kotenko SV; Smith GL
    J Gen Virol; 2005 Jun; 86(Pt 6):1589-1596. PubMed ID: 15914836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of type III interferon expression.
    Iversen MB; Paludan SR
    J Interferon Cytokine Res; 2010 Aug; 30(8):573-8. PubMed ID: 20645874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-lambda 1: similarities with type I interferon signaling.
    Dumoutier L; Tounsi A; Michiels T; Sommereyns C; Kotenko SV; Renauld JC
    J Biol Chem; 2004 Jul; 279(31):32269-74. PubMed ID: 15166220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense.
    Zhang SY; Boisson-Dupuis S; Chapgier A; Yang K; Bustamante J; Puel A; Picard C; Abel L; Jouanguy E; Casanova JL
    Immunol Rev; 2008 Dec; 226():29-40. PubMed ID: 19161414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons.
    Pfeffer LM; Dinarello CA; Herberman RB; Williams BR; Borden EC; Bordens R; Walter MR; Nagabhushan TL; Trotta PP; Pestka S
    Cancer Res; 1998 Jun; 58(12):2489-99. PubMed ID: 9635566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The comparative anti-herpes simplex virus effects of human interferons.
    Taylor JL; Little SD; O'Brien WJ
    J Interferon Cytokine Res; 1998 Mar; 18(3):159-65. PubMed ID: 9555977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-lambda: a new addition to an old family.
    Donnelly RP; Kotenko SV
    J Interferon Cytokine Res; 2010 Aug; 30(8):555-64. PubMed ID: 20712453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type I, II, and III Interferons: Regulating Immunity to Mycobacterium tuberculosis Infection.
    Travar M; Petkovic M; Verhaz A
    Arch Immunol Ther Exp (Warsz); 2016 Feb; 64(1):19-31. PubMed ID: 26362801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post HCV Infection Due to MX Gene Stimulation Produced Post Treatment with Imported and Locally Produced Egyptian Biosimilar IFN.
    Mohamed SH; Mahmoud NF; Mohamed AF; Kotb NS
    Asian Pac J Cancer Prev; 2015; 16(14):5635-41. PubMed ID: 26320428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.